Literature DB >> 19707804

Change in blood test after irradiation with high doses for inactivation of Lassa virus.

K Eberlein1, G Hintereder, S Schilling, C Rödel, L Jüling-Pohlit.   

Abstract

In 2006 we had a patient with Lassa fever in the University Hospital of Frankfurt. To insure a short turn-around time from the laboratory, it was necessary to have blood which was not contaminated with viruses. One method of achieving this is by irradiating the blood with high doses of ionising radiation. Inactivation of arena viruses requires doses between 12 kGy and 20 kGy, depending on temperature. In this study we investigated if plasma and serum parameters are changed by irradiation with 5 kGy, 10 kGy, 15 kGy, 20 kGy or 40 kGy of 10 MeV electrons. For the 22 serum parameters measured there was no influence of radiation up to 20 kGy. Only at 40 kGy was a significant decrease noted. For the six plasma parameters the values were significantly dose dependent. To correct this a mathematical function was defined. It is possible to inactivate Lassa virus with high doses of radiation. Most of the measured blood values don't change. For those which were influenced it was possible to define a mathematical function.

Entities:  

Mesh:

Year:  2009        PMID: 19707804     DOI: 10.1007/s10096-009-0750-4

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  3 in total

Review 1.  Lassa virus.

Authors:  Stephan Günther; Oliver Lenz
Journal:  Crit Rev Clin Lab Sci       Date:  2004       Impact factor: 6.250

2.  Inactivation of Lassa, Marburg, and Ebola viruses by gamma irradiation.

Authors:  L H Elliott; J B McCormick; K M Johnson
Journal:  J Clin Microbiol       Date:  1982-10       Impact factor: 5.948

3.  Physicochemical inactivation of Lassa, Ebola, and Marburg viruses and effect on clinical laboratory analyses.

Authors:  S W Mitchell; J B McCormick
Journal:  J Clin Microbiol       Date:  1984-09       Impact factor: 5.948

  3 in total
  1 in total

1.  Validation of Inactivation Methods for Arenaviruses.

Authors:  Silke Olschewski; Anke Thielebein; Chris Hoffmann; Olivia Blake; Jonas Müller; Sabrina Bockholt; Elisa Pallasch; Julia Hinzmann; Stephanie Wurr; Neele Neddersen; Toni Rieger; Stephan Günther; Lisa Oestereich
Journal:  Viruses       Date:  2021-05-24       Impact factor: 5.048

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.